BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
All of the shares of common stock are being offered by the Company.
The net proceeds from the offering will be used to purchase gold bullion, for working capital, and for general corporate purposes.
Merger with Streamex
BioSig recently merged with Streamex Exchange Corporation.
Offering Details
The offering is being made through an underwritten public offering of common stock.
Use of Proceeds
The net proceeds will be used for purchasing gold bullion, working capital, and general corporate purposes.
- The completion of the offering is subject to market conditions.
- Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Interested parties should read the preliminary prospectus supplement and accompanying base prospectus before investing in this offering. The Company's intention to purchase gold bullion with the net proceeds showcases a strategic investment move.